Fig. 3: Scatter plot of change in alcohol cue-elicited activation (ALC-NON) from baseline to scan 2 in each medication group for the medial orbitofrontal cortex (OFC) (left), right ventral striatum (VS) (middle), and right OFC (right) with change in heavy drinking days (HDDs) from baseline to scan 2. | Neuropsychopharmacology

Fig. 3: Scatter plot of change in alcohol cue-elicited activation (ALC-NON) from baseline to scan 2 in each medication group for the medial orbitofrontal cortex (OFC) (left), right ventral striatum (VS) (middle), and right OFC (right) with change in heavy drinking days (HDDs) from baseline to scan 2.

From: Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial

Fig. 3

Fit lines, 95% confidence intervals, and spearman correlations (ρ) are included for each region of interest.

Back to article page